Proliferative glomerulonephritis with monoclonal IgG deposits secondary to chronic lymphocytic leukemia. Report of two cases

Nephrology Dialysis Transplantation

Volumn 26, Issue 8, 2011, Pages 2712-2714

  Barbour, Sean J ^a   Beaulieu, Monica C ^a   Zalunardo, Nadia Y ^a   Magil, Alex B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

chronic lymphocytic leukemia; glomerulonephritis; monoclonal IgG; rituximab

Indexed keywords

CD20 ANTIGEN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C3; CREATININE; CYCLOPHOSPHAMIDE; FLUDARABINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN KAPPA CHAIN; RITUXIMAB;

ADULT; AGED; ANEMIA; ARTICLE; CANCER GRADING; CANCER INFILTRATION; CASE REPORT; CHRONIC LYMPHATIC LEUKEMIA; CREATININE BLOOD LEVEL; DRUG DOSE REDUCTION; DRUG RESPONSE; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY CORTEX; LEG EDEMA; LYMPHOCYTE COUNT; LYMPHOCYTOSIS; MALE; MULTIPLE CYCLE TREATMENT; NEUTROPENIA; PERIORBITAL EDEMA; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROLIFERATIVE GLOMERULONEPHRITIS WITH MONOCLONAL IMMUNOGLOBULIN G DEPOSIT; PROTEIN ELECTROPHORESIS; PROTEINURIA; TREATMENT DURATION; URINALYSIS;

AGED; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTINEOPLASTIC AGENTS; CYCLOPHOSPHAMIDE; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMUNOGLOBULIN G; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MALE; MIDDLE AGED; TREATMENT OUTCOME; VIDARABINE;

EID: 79961065887     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr251     Document Type: Article

References (10)

1. Nasr SH, Satoskar A, Markowitz G et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol 2009;20:2055-2064
2. Bhat P, Weiss S, Appel G et al. Rituximab treatment of dysproteinemias affecting the kidney: a review of three cases. Am J Kidney Dis 2007;50:641-644 (Pubitemid 47444457)
3. Seney FD Jr, Federgreen W, Stein H Jr et al. A review of nephrotic syndrome associated with chronic lymphocytic leukemia. Arch Intern Med 1986;146:137-141 (Pubitemid 16158642)
4. Touchard G, Preud'homme J, Aucouturier P et al. Nephrotic syndrome associated with chronic lymphocytic leukemia: an immunological and pathological study. Clin Nephrol 1989;31:107-116 (Pubitemid 19061044)
5. Takahashi F, Ogawa Y, Hasebe N et al. Successful treatment of a patient with nephrotic syndrome associated with chronic lymphocytic leukemia. Intern Med 2000;39:256-259 (Pubitemid 30204920)
6. Touchard G, Bauwens M, Goujon J et al. Glomerulonephritis with organized microtubular monoclonal immunoglobulin deposits. Adv Nephrol Necker Hosp 1994;23:149-175
7. Touchard G, Preud'homme JL. Nephrotic syndrome in chronic lymphocytic leukemia. Clin Nephrol 1997;47:131-133 (Pubitemid 27077749)
8. Grey HM, Hirst JW, Cohn M. A new mouse immunoglobulin: IgG3. J Exp Med 1971;133:289-304
9. Capra JD, Kunkel HG. Aggregation of gamma-G3 proteins: relevance to the hyperviscosity syndrome. J Clin Invest 1970;49:610-621
10. Hallek M, Cheson B, Catovsky D et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on chronic lymphocytic leukemia updating the National Cancer Institute-Working Group 1996 guidelines. Blood 2008;111:5446-5456